Story thread · 6 reports / 2 sources
CytoDyn Inc. to Present at the Life Sciences Investor Forum on September 17th
financialpost.com · 1h
VANCOUVER, Wash., Sept. 15, 2026 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a clinical-stage oncology company advancing leronlimab, a first-in-class humanized monoclonal antibody targeting the CCR5 receptor with therapeutic potential across multiple indications, including metastatic colorectal cancer (mCRC) and triple-negative breast cancer (TNBC), today announced that Robert E. Hoffman, Chief Financial Officer, […]
First report: Life Sciences Virtual Investor Forum Agenda Announced — financialpost.com, 1d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.